highly significantp<0.001
The baseline and endpoint score differences for patients in each arm were highly significant (p<0.001).
The baseline and endpoint score differences for patients in each arm were highly significant (p<0.001).
The score differences were significant for patients receiving 48 weeks azathioprine (p = 0.0002) and almost significant for patients in arms 1 and 3 (P values 0.0505 and 0.0512 respectively).